What we know about TMEM106B in neurodegeneration Alexandra M. NicholsonRosa Rademakers Review 20 August 2016 Pages: 639 - 651
Risk factor SORL1: from genetic association to functional validation in Alzheimer’s disease Olav M. AndersenIna-Maria RudolphThomas E. Willnow Review Open access 16 September 2016 Pages: 653 - 665
TREM1 facilitates microglial phagocytosis of amyloid beta Teng JiangYing-Dong ZhangJin-Tai Yu Original Paper 26 September 2016 Pages: 667 - 683
Mesenchymal stem cells enhance α-synuclein clearance via M2 microglia polarization in experimental and human parkinsonian disorder Hyun Jung ParkSe Hee OhPhil Hyu Lee Original Paper 06 August 2016 Pages: 685 - 701
Down-regulation of neuronal L1 cell adhesion molecule expression alleviates inflammatory neuronal injury Lutz MenzelMagdalena PaterkaMichael K. E. Schäfer Original Paper 20 August 2016 Pages: 703 - 720
Co-regulation of mRNA translation by TDP-43 and Fragile X Syndrome protein FMRP Pritha MajumderJen-Fei ChuChe-Kun James Shen Original Paper Open access 12 August 2016 Pages: 721 - 738
The pathogenic relevance of αM-integrin in Guillain–Barré syndrome Chaoling DongSteven P. PalladinoEroboghene E. Ubogu Original Paper 26 July 2016 Pages: 739 - 752
Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK Andrew C. RobinsonLaura PalmerDavid M. A. Mann Correspondence 15 September 2016 Pages: 753 - 755
Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation Joanna J. PhillipsHenry GongJoseph T. Shieh Correspondence 13 September 2016 Pages: 757 - 760
Frequent alternative lengthening of telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomas Fausto J. RodriguezM. Adelita VizcainoChristopher M. Heaphy Correspondence 20 September 2016 Pages: 761 - 763